Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Update on the antitumor efficacy of MDX-010

June 28, 2004

Panvac-VF enters phase III trial for pancreatic cancer

June 23, 2004

AMD-3100 improves the eligibility of MM patients for stem cell transplantation

June 23, 2004

FDA accepts Genmab IND for phase I/II study of HuMax-CD20 in CLL

June 22, 2004

Phase II data supports progression of Onyvax-P for advanced prostate cancer

June 22, 2004

Full enrollment in phase III Virulizin trial

June 21, 2004

PSMA-targeting immunotherapies presented at ASCO

June 21, 2004

Insegia chosen as trade name for G17DT

June 18, 2004

Polyvalent vaccine reported to improve survival in advanced melanoma

June 18, 2004

Pivotal phase III trial of Rencarex for renal cell carcinoma opens enrollment

June 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...